The Lancet HIV launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence. The monthly journal provides readers with context and insight into the clinical advances and practice-changing research shaping the study of HIV/AIDS today.
Now is a critical moment in the fight against HIV/AIDS. Despite the world view that the end of AIDS may be within reach, the job of controlling this epidemic is certainly not done. As HIV disease evolves to become a chronic infection, the interaction of the virus with other chronic conditions will present a host of new challenges. The Lancet HIV is a journal for a new era in the history of HIV/AIDS.
The Lancet HIV builds on The Lancet journals' reputation for publishing HIV/AIDS research to provide a reliable foundation for advocacy and for programmatic and political change. We will consider clinical, epidemiological, operational, and implementation research, unifying these disciplines across a single vision for the health of those living with HIV.
Following in The Lancet tradition, the journal is stringently edited and peer-reviewed to ensure scientific merit and clinical relevance. All original research is Fast Track peer reviewed for online publication within 8 weeks of submission and receives global exposure to the medical HIV/AIDS community via our online platforms thelancet.com and ScienceDirect. For selected high-impact research, the journal has a dedicated press office to facilitate worldwide media coverage, ensuring extensive global exposure of your research.